Mark Brecher, MD
University of North Carolina, Chapel Hill
1
1
0
N/A
0
0
Research Impact
N/A
Research impact score
0
Total publications
0
Published trial results
0
Total citations
Drug Portfolio
Analytics
Trial Phases
Trial Status
Role Distribution
Activity Timeline
Clinical Trials (1)
Research Network
Collaboration Network
Research Areas & Affiliations
Therapeutic Areas
Affiliations
Similar Key Opinion Leaders
Discover other key opinion leaders with similar research profiles, therapeutic areas, and collaboration networks.
Karin BILGER, MD
Hôpital de Haute-Pierre, Strasbourg
Shared therapeutic areas:
Marie-Christine THOURET, MD
CHU de l'Archet 2, Nice
Shared therapeutic areas:
Hubert NIVET, MD, PhD
Hôpital Gatien de Clovheville, Tours
Shared therapeutic areas:
Jacques POURRAT, MD, PhD
Hôpital de Rangueil, Toulouse
Shared therapeutic areas:
Sylvain LAVOUÉ, PH
CHU Pontchaillou, Service de maladies infectieuses et réanimation médicale, RENNES
Shared therapeutic areas:
Philippe VANHILLE, MD
CH de Valenciennes, Valenciennes
Shared therapeutic areas:
Cécile FOHRER, MD
Hôpital de Haute-Pierre, Strasbourg
Shared therapeutic areas:
Alain WYNCKEL, MD
CHU de Reims, Reims
Shared therapeutic areas:
Jean-Louis PALLOT, MD
CHI André Grégoire, Montreuil
Shared therapeutic areas:
François MAURIER, PH
Hôpital Sainte-Blandine Service de Médecine Interne, METZ
Shared therapeutic areas:
Publications (0)
No publications found for this investigator.
Clinical Trials (1)
Showing 1 of 1 trials
Evaluating the Effectiveness of Adding Rituximab to Standard Treatment for Thrombotic Thrombocytopenic Purpura (TTP)
All 1 trials loaded